Skip to Main Content

Paper Details

Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab.
J Immunother Cancer
5
2022
Author NameAffiliation
Hal K BermanUniversity Health Network, Princess Margaret Cancer Centre
Philippe L BedardUniversity Health Network, Princess Margaret Cancer Centre
David W CesconUniversity Health Network, Princess Margaret Cancer Centre
Tak W MakUniversity of Toronto
Lillian L SiuUniversity Health Network, Princess Margaret Cancer Centre
  • 1 - 5

Datasets

Release 1.2